Hanna Ljung

Medicine & Life Sciences

1. Temporal Lobe Epilepsy 100%
2. perampanel 64%
3. Memory 62%
4. Anticonvulsants 60%
5. Zonisamide 57%
6. Levetiracetam 51%
7. Magnetic Resonance Imaging 50%
8. Topiramate 50%
9. Out-of-Hospital Cardiac Arrest 49%
10. flutemetamol 47%
11. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 45%
12. Partial Epilepsy 45%
13. Drug Resistant Epilepsy 43%
14. Economic Inflation 43%
15. Omega-3 Fatty Acids 42%
16. Patient Rights 41%
17. Hypothermia 40%
18. Temporal Lobe 39%
19. Memory and Learning Tests 39%
20. Heart Arrest 38%
21. Epilepsy 36%
22. Amyloid 36%
23. Seizures 34%
24. Case-Control Studies 30%
25. Hippocampus 30%
26. Pathology 26%
27. Elderly 25%
28. Safety 23%
29. Positron-Emission Tomography 23%
30. Sclerosis 19%
31. Eicosapentaenoic Acid 18%
32. Docosahexaenoic Acids 18%
33. Pharmacology 17%
34. Generalized Epilepsy 17%
35. Mental Disorders 16%
36. Carbamazepine 14%
37. Carotid Stenosis 14%
38. Nervous System Diseases 14%
39. Language 14%
40. Licensure 13%
41. Middle Cerebral Artery 13%
42. Expert Testimony 13%
43. Clinical Trials 13%
44. Cerebrovascular Circulation 12%
45. Therapeutics 11%
46. Child 11%
47. Myocardial Infarction 10%
48. Executive Function 9%
49. Meta-Analysis 9%
50. Arteries 9%